1. Home
  2. TKLF vs CANF Comparison

TKLF vs CANF Comparison

Compare TKLF & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yoshitsu Co. Ltd

TKLF

Yoshitsu Co. Ltd

SELL

Current Price

$1.58

Market Cap

8.4M

ML Signal

SELL

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

N/A

Current Price

$1.79

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TKLF
CANF
Founded
2006
1994
Country
Japan
Israel
Employees
160
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
6.7M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
TKLF
CANF
Price
$1.58
$1.79
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $7.50
AVG Volume (30 Days)
11.5K
★ 28.3K
Earning Date
07-10-2026
09-08-2026
Dividend Yield
★ 15.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.82
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$0.17
52 Week High
$3.62
$10.40

Technical Indicators

Market Signals
Indicator
TKLF
CANF
Relative Strength Index (RSI) 41.38 21.36
Support Level $1.30 N/A
Resistance Level $1.63 $2.27
Average True Range (ATR) 0.09 0.08
MACD 0.01 -0.00
Stochastic Oscillator 63.64 0.00

Price Performance

Historical Comparison
TKLF
CANF

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, electronic products, and other products. It sells its products through directly operated physical stores, online stores, and franchise stores and wholesale customers. It operates through directly operated physical stores, online stores and services, and franchise stores and wholesale customers segments, with the franchise stores and wholesale customers segment generating maximum revenue. Geographically, it generates maximum revenue from Hong Kong.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: